Literature DB >> 21633099

Malignancies after renal transplantation in Taiwan: a nationwide population-based study.

Wei-Hsuan Li1, Yi-Ju Chen, Wei-Cheng Tseng, Ming-Wei Lin, Tzeng-Ji Chen, Szu-Ying Chu, Chian-Yaw Hwang, Chih-Chiang Chen, Ding-Dar Lee, Yun-Ting Chang, Wen-Jen Wang, Han-Nan Liu.   

Abstract

BACKGROUND: Renal transplantation has been regarded as the treatment of choice for end-stage renal disease. Renal transplantation increases the risk of cancers due to long-term immunosuppression. The types of post-transplantation malignancies may vary among different geographic regions and ethnic populations. To date, large population-based studies of post-transplantation malignancies in Asian renal transplant recipients (RTRs) have rarely been reported.
METHODS: To investigate the patterns of post-transplantation malignancies in Chinese RTRs, we performed a nationwide population-based cohort study between 1997 and 2008 based on data from the National Health Insurance Database in Taiwan. Patterns of cancer incidence in RTRs were compared with those of the general population using standardized incidence ratios (SIRs).
RESULTS: Among the 4716 RTRs (2475 males and 2241 females; mean age 44.1 ± 12.4 years) and 22 556 person-years of observation, 320 post-transplant cancers were diagnosed. The SIR of all cancers was 3.75 (95% confidence interval 3.36-4.18). Women had a higher risk than men for the development of malignancies (SIR 5.04 for women and SIR 2.88 for men). Renal, bladder and liver cancers were the most common cancers, with SIRs of 44.29, 42.89 and 5.07, respectively. When stratified by age, RTRs of young age at transplant (<20 years) had the highest risk of post-transplantation malignancies.
CONCLUSIONS: This study demonstrates different patterns of malignancies after renal transplantation in Chinese RTRs, with higher incidences of kidney and bladder cancers. Physicians should be more vigilant in examining RTRs for post-transplantation malignancies especially in younger patients.

Entities:  

Mesh:

Year:  2011        PMID: 21633099     DOI: 10.1093/ndt/gfr277

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  34 in total

1.  Cancer risk in patients receiving renal replacement therapy: A meta-analysis of cohort studies.

Authors:  Weifeng Shang; Liu Huang; Li Li; Xiaojuan Li; Rui Zeng; Shuwang Ge; Gang Xu
Journal:  Mol Clin Oncol       Date:  2016-07-07

2.  Incidence, risk factors and outcomes of malignancies after kidney transplantation in Singapore: a 12-year experience.

Authors:  Su Hooi Teo; Kian-Guan Lee; Gek Hsiang Lim; Si Xuan Koo; Maria Erika Ramirez; Khuan Yew Chow; Terence Kee
Journal:  Singapore Med J       Date:  2018-10-10       Impact factor: 1.858

Review 3.  De Novo Malignancies after Kidney Transplantation.

Authors:  David Al-Adra; Talal Al-Qaoud; Kevin Fowler; Germaine Wong
Journal:  Clin J Am Soc Nephrol       Date:  2021-03-29       Impact factor: 8.237

4.  Upper urinary tract urothelial carcinoma behaviors in patients with end-stage renal disease after kidney transplantation in Taiwan.

Authors:  Chia-Shen Chien; Hao Lun Luo; Chou Shu Ling; Po-Hui Chiang; Yen-Ta Chen; Yuan Tso Cheng
Journal:  Int Urol Nephrol       Date:  2016-05-18       Impact factor: 2.370

5.  The risk of cancer in patients with congenital heart disease: a nationwide population-based cohort study in Taiwan.

Authors:  Yu-Sheng Lee; Yung-Tai Chen; Mei-Jy Jeng; Pei-Chen Tsao; Hsiu-Ju Yen; Pi-Chang Lee; Szu-Yuan Li; Chia-Jen Liu; Tzeng-Ji Chen; Pesus Chou; Wen-Jue Soong
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

6.  Increased risks of mortality and atherosclerotic complications in incident hemodialysis patients subsequently with bone fractures: a nationwide case-matched cohort study.

Authors:  Chiu-Huang Kuo; Tsung-Cheng Hsieh; Chih-Hsien Wang; Chu-Lin Chou; Yu-Hsien Lai; Yi-Ya Chen; Yu-Li Lin; Sheng-Teng Wu; Te-Chao Fang
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

7.  Increased risk of hepatic complications in kidney transplantation with chronic virus hepatitis infection: A nationwide population-based cohort study.

Authors:  Tung-Min Yu; Che-Chen Lin; Kuo-Hsiung Shu; Ya-Wen Chuang; Shih-Ting Huang; Cheng-Hsu Chen; Ming-Ju Wu; Mu-Chi Chung; Chao-Hsiang Chang; Chi-Yuan Li; Chi-Jung Chung
Journal:  Sci Rep       Date:  2016-02-19       Impact factor: 4.379

8.  Sex differences in the development of malignancies among end-stage renal disease patients: a nationwide population-based follow-up study in Taiwan.

Authors:  Chi-Jung Chung; Chao-Yuan Huang; Hung-Bin Tsai; Chih-Hsin Muo; Mu-Chi Chung; Chao-Hsiang Chang; Chiu-Ching Huang
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

9.  Risk of bladder cancer in renal transplant recipients: a meta-analysis.

Authors:  L Yan; P Chen; E-Z Chen; A Gu; Z-Y Jiang
Journal:  Br J Cancer       Date:  2014-02-04       Impact factor: 7.640

10.  Cancer Incidence among Heart, Kidney, and Liver Transplant Recipients in Taiwan.

Authors:  Kwai-Fong Lee; Yi-Ting Tsai; Chih-Yuan Lin; Chung-Bao Hsieh; Sheng-Tang Wu; Hung-Yen Ke; Yi-Chang Lin; Feng-Yen Lin; Wei-Hwa Lee; Chien-Sung Tsai
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.